Bo-Eun Yoon

Title: Bo-Eun Yoon: Innovator in GABA Release Regulation

Introduction

Bo-Eun Yoon is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of neuroscience, particularly in the regulation of GABA (gamma-aminobutyric acid) release in the cerebellum. His innovative work aims to address pathological symptoms associated with GABA dysregulation.

Latest Patents

Bo-Eun Yoon holds a patent for a GABA release-regulating agent in the cerebellum. This patent includes a GABA release-inhibiting agent and a composition for treating symptoms caused by the over-release of GABA, utilizing a Bestrophin 1 (Best1) channel inhibitor as an active ingredient. Additionally, it features a GABA release-promoting agent and a composition for treating symptoms caused by GABA deficiency, which includes a Best1 channel activator. The patent also outlines a method for screening a GABA release-regulating agent in the cerebellum, targeting the Best1 channel.

Career Highlights

Bo-Eun Yoon is affiliated with the Korea Institute of Science and Technology, where he continues to advance research in his field. His work has garnered attention for its potential therapeutic applications in treating neurological disorders.

Collaborations

He collaborates with esteemed colleagues, including ChangJoon Justin Lee and Soo-Jung Lee, contributing to a dynamic research environment that fosters innovation.

Conclusion

Bo-Eun Yoon's contributions to the understanding and regulation of GABA release in the cerebellum highlight his role as a key innovator in neuroscience. His patent reflects a significant advancement in potential treatments for GABA-related disorders.